文献速递耳科与耳神经

肝素辅助治疗重度特发性突发性感音神经性聋

Heparin therapy as adjuvant treatment for profound idiopathic sudden sensorineural hearing loss.
PubMed 文献 · Laryngoscope · 2019-08-09

结果显示肝素组42.8%恢复可用听力,显著高于ITSI组的19.7%;在初始听力90-100 dB患者中肝素组显著恢复率达80%,但初始听力>100 dB者两组恢复率均不理想。

要点

  • 肝素辅助全身激素治疗重度ISSNHL的听力恢复率显著高于联合鼓室内激素注射。
  • 初始听力90-100 dB患者中肝素辅助治疗显著恢复率达80%。
  • 初始听力>100 dB者两组恢复率均低且不理想。

核心结论

  • 重度ISSNHL患者采用肝素辅助联合全身激素治疗,相比联合局部与全身激素治疗,听力恢复率更高且无严重并发症。

主要发现

  • 肝素组42.8%恢复可用听力,显著高于ITSI组的19.7%。
  • 初始听力90-100 dB患者中,肝素辅助治疗显著恢复率达80%。
  • 初始听力>100 dB患者中,ITSI组显著恢复率为8.1%,肝素组为9.1%,两组大致相等且不理想。

关键数值与推荐

  • 听力恢复按美国耳鼻咽喉头颈外科学会标准进行分级评估。

临床怎么用

  • 对重度ISSNHL(≥90 dB)患者,尤其是初始听力90-100 dB者,可考虑在全身激素基础上加用肝素辅助治疗以提高听力恢复率。

局限性

  • 研究为回顾性设计,证据等级为3b。
  • 肝素组样本量较小(21例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: This study aimed to provide evidence of whether unfractionated heparin used as adjuvant therapy in conjunction with systemic corticosteroid therapy improves hearing recovery in patients with profound idiopathic sudden sensorineural hearing loss (ISSNHL), and to compare the effect of this treatment with those of additional intratympanic corticosteroid therapy. STUDY DESIGN: Retrospective chart review. METHODS: Eighty-seven patients with profound ISSNHL (≥90 dB) and who had been admitted at a tertiary referral center between 2010 and 2018 were retrospectively reviewed, 67 patients for additional intratympanic corticosteroid injection (ITSI) (ITSI group) and 21 for adjuvant heparin therapy (heparin group). Hearing recovery was evaluated by grade assessment according to the American Academy of Otolaryngology-Head and Neck Surgery criteria. RESULTS: Of the patients in the heparin group, 42.8% recovered serviceable hearing, which was significantly higher than the recovery rates (19.7%) of those in the ITSI group. Particularly, in patients with pretreatment hearing level of 90 to 100 dB, adjuvant heparin therapy enhanced therapeutic effects with a significant hearing recovery rate of 80%. However, in patients with initial hearing level >100 dB, the rates of significant hearing recovery in the two groups were roughly equal and remained unsatisfactory (8.1% in the ITSI group and 9.1% in the heparin group). CONCLUSIONS: The results of this study suggest that the treatment of profound ISSNHL with adjuvant heparin therapy, in combination with systemic steroid therapy, results in higher hearing recovery rates when compared to combined local and systemic corticosteroid therapy, without serious complications. LEVEL OF EVIDENCE: 3b Laryngoscope, 130:1310-1315, 2020.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Kim J, Jeong J, Ha R, et al. Heparin therapy as adjuvant treatment for profound idiopathic sudden sensorineural hearing loss. Laryngoscope. 2019. PMID: 31397902. doi:10.1002/lary.28231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。